Glipizide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Glipizide
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Glipizide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 17 USDMF, 5 CEP/COS, 5 EU WC, 16 NDC API, 19 Listed Suppliers, $ API Reference Price

29 API Suppliers
17 USDMF
5 CEP/COS
5 EU WC
16 NDC API
19 Listed Suppliers
$ API Reference Price

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers, 73 FDA Orange Book, 4 Europe, 4 Australia, 1 South Africa, 20 Listed Dossiers

102 FDF Dossiers
73 FDA Orange Book
4 Europe
4 Australia
1 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 2.5MG, TABLET, EXTENDED RELEASE;ORAL - 5MG

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 10MG
TABLET, EXTENDED RELEASE;ORAL - 2.5MG
TABLET, EXTENDED RELEASE;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 5 SPI Pharma, 2 Seqens, 14 DKSH, 6 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 32 BASF, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 45 Controlled & Modified Release, 36 Direct Compression, 34 Disintegrants & Superdisintegrants, 32 Solubilizers, 31 Thickeners and Stabilizers, 29 Lubricants & Glidants, 25 Topical, 25 Granulation, 21 Film Formers & Plasticizers, 21 Co-Processed Excipients, 18 Parenteral, 11 Taste Masking, 9 Emulsifying Agents, 8 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules

86 Fillers, Diluents & Binders
76 Coating Systems & Additives
45 Controlled & Modified Release
36 Direct Compression
34 Disintegrants & Superdisintegrants
32 Solubilizers
31 Thickeners and Stabilizers
29 Lubricants & Glidants
25 Topical
25 Granulation
21 Film Formers & Plasticizers
21 Co-Processed Excipients
18 Parenteral
11 Taste Masking
9 Emulsifying Agents
8 Rheology Modifiers
8 Chewable & Orodispersible Aids
7 API Stability Enhancers
5 Coloring Agents
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 13 Finished Drug Prices

2 US Medicaid Prescriptions
13 Finished Drug Prices

MARKET PLACE

5 APIs, 2 FDF Dossiers

5 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities, 2 Health Canada Patents

1 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 2 USP, 13 Others

5 EDQM
2 USP
13 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 277 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Blank

filter Patent Reset all filters

2 All

01 21222950

filter Product Reset all filters

2 All

01 2Blank

filter Dosage Reset all filters

2 All

01 2Blank

filter Exp Date Reset all filters

2 All

01 22004-06-16

Product Main Page

01

Glipizide

Pharma, Lab & Chemical Expo

Not Confirmed

Country

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2004-06-16

Date Granted :

Brand Name :

Patent Number : 1222950

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-06-16

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Glipizide

Pharma, Lab & Chemical Expo

Not Confirmed

Country

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2004-06-16

Date Granted :

Brand Name :

Patent Number : 1222950

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-06-16

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?